ClinicalTrials.gg
RecruitingNCT07794605SPRINTUpdated Nov 2, 2026

Sleep to Predict Recovery In Unconscious Patients With Acute Brain Injury

An observational study in Traumatic Brain Injury (TBI) Patients and Intracerebral Hemorrhage (ICH), sponsored by Columbia University. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Columbia University · Observational

Updated Nov 2, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
230
Ages
18 Years and older
Sex
All
01

Study summary

Severe brain injuries can leave people in states where they are unconscious or only partly aware, such as a coma. These conditions are common after injuries like head trauma or bleeding in the brain. One of the biggest challenges for doctors is knowing if - or when - a patient will wake up and regain awareness.

This research study is being done to determine if patterns in brain activity during sleep (measured by EEG) can help doctors better predict how quickly someone will wake up and recover after a serious brain injury, as well as how well they might do in the long term. It also aims to develop new ways of using EEG to track how the brain's networks heal and reconnect over time.

Read the detailed description

Disorders of consciousness (DoC), including coma and other states of impaired awareness, are common following severe acute brain injury, particularly traumatic brain injury (TBI) and intracerebral hemorrhage (ICH). Predicting whether and when these patients will recover consciousness remains one of the greatest challenges in neurocritical care. Current prognostic tools are limited, and inaccurate predictions may influence critical decisions regarding ongoing treatment and goals of care.

Previous work has demonstrated that cognitive motor dissociation (CMD) - brain activation detected by EEG in response to motor commands despite the absence of observable behavioral responses - is associated with long-term recovery. However, CMD testing has important limitations, including false-negative results in patients with aphasia, hearing impairment, language barriers, or fluctuating arousal.

Sleep architecture is profoundly disrupted after severe brain injury. Emerging evidence suggests that the presence of well-formed sleep spindles (WFSS) on EEG reflects preserved thalamocortical network integrity and is associated with recovery of consciousness and improved neurological outcomes. Sleep spindle detection offers a potentially scalable, inexpensive, and language-independent biomarker that can be obtained passively during routine EEG monitoring.

This study seeks to determine whether EEG sleep features, particularly WFSS, can improve prediction of early recovery of consciousness and long-term neurological outcomes while also developing novel EEG-based measures of functional network recovery.

02

Conditions studied

  • Traumatic Brain Injury (TBI) Patients
  • Intracerebral Hemorrhage (ICH)

Keywords

  • cognitive motor dissociation (CMD)
  • Disorders of Consciousness
03

In context

Brain Injuries, Traumatic

1,721 studies on the registry are indexed under Brain Injuries, Traumatic; 447 are open to participants now.

This study's planned enrollment of 230 is above the median of 117 across 557 observational studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

Columbia University is the lead sponsor of 1,136 studies on the registry; 195 are open to participants now.

Of its 180 completed or terminated interventional studies of FDA-regulated products, 148 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients admitted to the ICU with acute neurological injury with Disorders of Consciousness (traumatic brain injury, and intracerebral hemorrhage) who demonstrate impaired consciousness and are unable to follow commands based on standardized clinical assessments (e.g., CRS-R).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Adults with non-penetrating traumatic brain injury (TBI) or with primary intracerebral hemorrhage (ICH) (i.e. from hypertension or anticoagulants) who remain behaviorally unresponsive to verbal commands (i.e., comatose vegetative state, or minimally conscious state minus [MCS-minus, defined as unresponsive with preserved visual fixation/pursuit or localization to noxious stimuli]) by day 2 after injury

Exclusion criteria

Exclusion Criteria:

  • Evidence of consciousness within 2 days of injury
  • Uncontrolled seizures
  • pre-existing disorders of consciousness
  • deafness
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
230 participants (estimated)
Patient registry
No

Groups and cohorts

  • Intracerebral Hemorrhage and Traumatic Brain Injury

    Adult patients with acute neurological injury with Disorders of Consciousness (traumatic brain injury, and intracerebral hemorrhage).

06

What researchers measure

Primary outcomes

  1. P-value for prediction of the detection of cognitive motor dissociation (CMD)

    P-value for separating move vs non-move instructions on power spectral density data using a support vector machine learning algorithm.

    Time frame: Day 9

  2. Prediction of recovery of consciousness by day 28 after brain injury

    Recovery of consciousness will be determined using the Coma Recovery Scale-Revised Scale (CRS-R) indexing consciousness as either minimally conscious state-plus (MCS-plus: the presence of signs of conscious awareness that include responses to commands or intelligible verbal output) or emergence from a minimally conscious state (EMCS: the return of the ability to use common objects in a functional manner or correctly respond to basic yes-or-no questions about situational orientation). Both would qualify as recovery of consciousness. The CRS-R full score ranges from 0 to 23, with higher scores representing higher levels of consciousness.

    Time frame: Day 28

  3. Sleep as a prognosticator of long-term independence and disability after traumatic brain injury (TBI)

    This outcome will be assessed using the Glasgow Outcome Scale-Extended (GOS-E) Scale, which is an 8-level standardized clinical scale used to measure functional recovery and independence after a brain injury. Higher GOS-E scores indicate a better recovery, higher functional independence, and a greater return to normal daily activities. GOS-E score of ≥4 by 12-month post injury will serve as the primary measure to define independence indicating that the participant can be left alone at home for at least 8 hours in a day.

    Time frame: 12 months post injury

  4. Sleep as a prognosticator of long-term disability after intracerebral hemorrhage (ICH)

    This outcome will be assessed using the Modified Rankin Scale (mRS). The full score ranges from 0 to 6, measuring the degree of disability or dependence in daily activities. Higher scores mean greater disability and dependence, whereas lower scores mean better recovery and independence. Recovery from disability will be set at a score of 3 or below by 12 months post injury, indicating no more than moderate disability, where a person requires some help with daily activities but is still able to walk without assistance.

    Time frame: 12 months post injury

Secondary outcomes

  1. Recovery of consciousness (CRS-R score ≥ 8)

    Number of participants who have a Coma Recovery Scale-Revised (CRS-R) score of 8 or above.

    Time frame: Day 28 after brain injury

  2. Recovery of consciousness (CRS-R score = 10)

    Number of participants who have a Coma Recovery Scale-Revised (CRS-R) score of 10.

    Time frame: Day 28 after brain injury

  3. Recovery of consciousness

    Presence of subtle clinical signs of consciousness

    Time frame: Day 28 after brain injury

  4. Recovery of consciousness using the CRSR-FAST

    Coma Recovery Scale-Revised For Accelerated Standardized Testing (CRSR-FAST) score does not use a numerical scoring range like the full-length test; instead, it results in a binary rating of "conscious" or "not conscious." If at least one of the five core behaviors are present, the participant is considered conscious.

    Time frame: Day 28 after brain injury

  5. Recovery of consciousness (mean CRS-R score)

    Average CRS-R scores following equal interval transformation using the partial credit Rash model.

    Time frame: Day 28 after brain injury

  6. Delirium as detected by the CAM-ICU score

    The CAM-ICU (Confusion Assessment Method for the Intensive Care Unit) is a bedside tool used to screen for delirium in critically ill or mechanically ventilated patients. Instead of a numeric point scale, it yields a positive or negative result for delirium based on four specific clinical features.

    Time frame: Day 28 after brain injury

  7. Recovery of independence for all patients

    Number of participants who have a Glasgow Outcome Scale-Extended score of ≥4

    Time frame: 12 month post injury

  8. Long term disability

    utility weighted transformation of modified Rankin Scale score

    Time frame: 12 months after injury

  9. Quality of life as per the Neuro-QOL scale

    Quality of Life in Neurological Disorders (Neuro-QOL) to quantify quality of life as a patient-reported outcome measure. Neuro-QOL uses a standardized T-score metric where the mean of a reference population is set at 50 and the standard deviation is 10. Scores above or below 50 represent better or worse health-related quality of life than the reference group, depending on the specific symptom or functional domain.

    Time frame: 12 months post injury

  10. Disability

    Disability will be evaluated using the Disability Rating Scale (DRS), which ranges from 0 to 29, where higher scores indicate a greater level of impairment.

    Time frame: 12 months post injury

  11. GOS-E sliding dichotomy for TBI participants

    Evaluating recovery after traumatic brain injury (TBI) using a sliding dichotomy with the IMPACT Score tailors the definition of a "favorable" functional outcome to each participant's unique baseline prognosis. Instead of applying a single fixed cutoff (e.g., GOS-E ≥ 4 for everyone), this method sets a customized recovery threshold for each participant based on their predicted baseline risk profile. A participant recovering better than their individual baseline prediction is classified as a "favorable" outcome

    Time frame: 12 months post injury

  12. GOS-E sliding dichotomy for ICH participants

    Evaluating recovery after intracerebral hemorrhage (ICH) using a sliding dichotomy with the FUNC Score tailors the definition of a "favorable" functional outcome to each participant's unique baseline prognosis. Instead of applying a single fixed cutoff, this method sets a customized recovery threshold for each participant based on their predicted baseline risk profile. A participant recovering better than their individual baseline prediction is classified as a "favorable" outcome.

    Time frame: 12 months

  13. Return to work

    Participants will be assessed if they were able to return to work as measured by the GOS-E with a score of 6 or above, indicating they are able to return to work even with special arrangements.

    Time frame: 12 months

07

Study locations

1 of 2 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Oct 2030, 48 months after the start.

Of 228 non-industry observational studies under Brain Injuries, Traumatic, half reached primary completion within 50 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 95. This study's planned 48 months is close to that.

Counting every sponsor, half of 250 studies reached it within 49 months; a quarter within 23 and three quarters within 95.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 2, 2026: start Sep 2026 → Oct 2026, primary completion Sep 2030 → Oct 2030 and completion Sep 2031 → Oct 2031.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 26, 2026
First posted
Aug 31, 2026
StartActual
Oct 30, 2026was Sep 2026
Primary completionEst.
Oct 30, 2030was Sep 2030
CompletionEst.
Oct 30, 2031was Sep 2031
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 2, 2026
Sites
2 sites changed recruiting status (1 now not yet recruiting, 1 now recruiting)
Show 2 sites
  • University of Miami and Jackson Health System (UM/JHS) · Miami, United Statesno status→Not yet recruiting
  • Columbia University Medical Center · New York, United Statesno status→Recruiting
Nov 2, 2026
Start date
Sep 1, 2026→Oct 30, 2026 (actual)
Nov 2, 2026
Primary completion
Sep 1, 2030→Oct 30, 2030
Nov 2, 2026
Study completion
Sep 1, 2031→Oct 30, 2031
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    Not yet recruiting→Recruiting
    2 sites changed recruiting status (1 now not yet recruiting, 1 now recruiting)
    Show 2 sites
    • University of Miami and Jackson Health System (UM/JHS) · Miami, United Statesno status→Not yet recruiting
    • Columbia University Medical Center · New York, United Statesno status→Recruiting
    Start date Sep 1, 2026→Oct 30, 2026 (now actual)
    Primary completion Sep 1, 2030→Oct 30, 2030
    Study completion Sep 1, 2031→Oct 30, 2031
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07794605
Responsible party
Jan Claassen (Professor of Neurology, Columbia University) — Principal investigator
First posted
Aug 31, 2026
Start date
Oct 30, 2026
Primary completion
Oct 30, 2030 (estimated)
Completion
Oct 30, 2031 (estimated)
Last update
Nov 2, 2026

Study contacts

Jan Claassen, MD
Contact
jc1439@cumc.columbia.edu
212-305-7236
Angela Velazquez, MD
Contact
agv2113@cumc.columbia.edu
212-305-6071

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion